Event coverage
ASCO 2018 - Monday 4th June: BMS tries different tack as Mer...
Merck & Co has dominated proceedings at the American Society of Clinical Oncology (ASCO), with a steady flow of data from its Keytruda checkpoint inhibitor drug at the conference in Chi
